Home › MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO (fluralaner)
 

Keywords :   


MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO (fluralaner)

2013-12-17 10:00:00| Merck.com - Corporate News

Dateline City: SUMMIT, N.J. New Chewable Tablet Treatment for Fleas and Ticks in Dogs Effective For 12 Weeks (8 weeks for Rhipicephalus sanguineus ticks) SUMMIT, N.J.--(BUSINESS WIRE)--MSD Animal Health (known as Merck Animal Health in the United States and Canada) today announced that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorization for the veterinary medicinal product BRAVECTO (fluralaner) chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg). Language: English Contact: MSD Animal HealthAmy Firsching, +1 908 473 6357amy.firsching@merck.comorPam Eisele, +1 908 423 5042pamela_eisele@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: health positive opinion agency

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
05.11Tropical Storm Rafael Wind Speed Probabilities Number 6
05.11Tropical Storm Rafael Public Advisory Number 6
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 6
05.11Why colouring clothes has a big environmental impact
05.11Atlantic Tropical Weather Outlook
More »